E1501

E1501

SCHEMBL9639366

CC(=O)OCc1ccccc1.CCNc1cccnc1N1CCNCC1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
ALDH1A1 P00352 1/20 0.44
SLC29A1 Q99808 1/20 0.41
GRIN2B Q13224 1/20 0.41
HTR6 P50406 3/20 0.39
CSNK1A1 P48729 1/20 0.39
HTR1A P08908 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LRRK2 Q5S007 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9640454 0.91 PARP1 (0.45) PARP1SLC29A1GRIN2BHTR6CSNK1A1
Propionic Acid SCHEMBL9640910 0.84 PARP1 (0.53) PARP1ALDH1A1HTR6HTR1A
SCHEMBL3334093 0.82 EPHX2 (0.51) PARP1HTR1A
Hydrochloric Acid SCHEMBL8703350 0.81 EPHX2 (0.50) PARP1ALDH1A1HTR1A
Water SCHEMBL8415043 0.81 EPHX2 (0.50) PARP1HTR1A
Hydrochloric Acid SCHEMBL9076651 0.80 PARP1 (0.49) PARP1ALDH1A1HTR1A
SCHEMBL9639712 0.80 PARP1 (0.46) PARP1ALDH1A1GRIN2BCSNK1A1L3MBTL1
SCHEMBL9640078 0.80 PARP1 (0.47) PARP1ALDH1A1
Acetic Acid SCHEMBL9639371 0.77 HTR3E (0.53) PARP1ALDH1A1HTR1A
SCHEMBL9639628 0.76 PARP1 (0.49) PARP1HTR6HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0496746-A1 PHARMACEUTICALLY ACTIVE AMINO-SUBSTITUTED HETEROARYL AMINES THE UPJOHN COMPANY (US) 1992-08-05 EP disclosed
WO-1991006542-A1 PHARMACEUTICALLY ACTIVE AMINO-SUBSTITUTED HETEROARYL AMINES THE UPJOHN COMPANY (US) 1991-05-16 WO disclosed